BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Diederich NJ, Uchihara T, Grillner S, Goetz CG. The Evolution-Driven Signature of Parkinson's Disease. Trends Neurosci 2020;43:475-92. [PMID: 32499047 DOI: 10.1016/j.tins.2020.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Bagarinao E, Kawabata K, Watanabe H, Hara K, Ohdake R, Ogura A, Masuda M, Kato T, Maesawa S, Katsuno M, Sobue G. Connectivity impairment of cerebellar and sensorimotor connector hubs in Parkinson’s disease. Brain Communications 2022;4. [DOI: 10.1093/braincomms/fcac214] [Reference Citation Analysis]
2 Sheng Y, Wang H, Chang X, Jin P, Lin S, Qian S, Xie J, Lu W, Yu X. Effect of Scalp Nerve Block Combined with Intercostal Nerve Block on the Quality of Recovery in Patients with Parkinson’s Disease after Deep Brain Stimulation: Protocol for a Randomized Controlled Trial. Brain Sciences 2022;12:1007. [DOI: 10.3390/brainsci12081007] [Reference Citation Analysis]
3 Qu M, Xing F, Xing N. Mesenchymal stem cells for the treatment of cognitive impairment caused by neurological diseases. Biotechnol Lett 2022. [PMID: 35809141 DOI: 10.1007/s10529-022-03274-7] [Reference Citation Analysis]
4 Takakusaki K, Takahashi M, Noguchi T, Chiba R. Neurophysiological mechanisms of gait disturbance in advanced Parkinson's disease patients. Neurology & Clinical Neurosc 2022. [DOI: 10.1111/ncn3.12605] [Reference Citation Analysis]
5 Nagatsu T, Nakashima A, Watanabe H, Ito S, Wakamatsu K. Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase. IJMS 2022;23:4176. [DOI: 10.3390/ijms23084176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Tekriwal A, Felsen G, Ojemann SG, Abosch A, Thompson JA. Motor context modulates substantia nigra pars reticulata spike activity in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2022;93:386-94. [PMID: 35193951 DOI: 10.1136/jnnp-2021-326962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Pérez-Fernández J, Barandela M, Jiménez-López C. The Dopaminergic Control of Movement-Evolutionary Considerations. Int J Mol Sci 2021;22:11284. [PMID: 34681941 DOI: 10.3390/ijms222011284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Onofrj M, Di Iorio A, Carrarini C, Russo M, Franciotti R, Espay AJ, Boylan LS, Taylor JP, Di Giannantonio M, Martinotti G, Valente EM, Thomas A, Bonanni L, Delli Pizzi S, Dono F, Sensi S. Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease. Mov Disord 2021. [PMID: 34427338 DOI: 10.1002/mds.28745] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Sun J, He C, Yan QX, Wang HD, Li KX, Sun X, Feng Y, Zha RR, Cui CP, Xiong X, Gao S, Wang X, Yin RX, Qiao GF, Li BY. Parkinson-like early autonomic dysfunction induced by vagal application of DOPAL in rats. CNS Neurosci Ther 2021;27:540-51. [PMID: 33475253 DOI: 10.1111/cns.13589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
10 Sujatha R, Poongodi T, Suganthi S. Remote Healthcare Monitoring for Parkinson’s Disease in a Smart Way. Internet of Things 2021. [DOI: 10.1007/978-3-030-63937-2_8] [Reference Citation Analysis]
11 Klimaschewski LP. Altern und neurodegenerative Erkrankungen – warum gehen Nervenzellen verloren? Parkinson und Alzheimer heute 2021. [DOI: 10.1007/978-3-662-63392-2_2] [Reference Citation Analysis]
12 Chen Y, Wang J, Kang Y, Ghori MB. Emergence of Beta Oscillations of a Resonance Model for Parkinson's Disease. Neural Plast 2020;2020:8824760. [PMID: 33335546 DOI: 10.1155/2020/8824760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]